Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | 7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid | HCID 14590421 | — |
| Product | HCID 22914227 | HCID 22914227 | 56% |
Reaction Steps
38.8 g (133 mmol) of 7-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylic acid were dissolved in 200 ml of N,N-dimethylformamide, treated portionwise with 23.7 g (146 mmol) of 1,1'-carbonyldiimidazole and stirred at 70° for 20 min. After adding 43.73 g (199.5 mmol) of phthaloylglycine amidoxime the mixture was stirred at 90° for 1 hour. 1.5 ml of trifluoroacetic acid were added and the mixture was stirred at 90° overnight and at 120° for a further 3 hours. The suspension obtained was concentrated to half of its volume and cooled, and the precipitated crystals were filtered off. There were obtained 35.3 g (56%) of 7-chloro-5,6-dihydro-5-methyl-3-(3-phthalimidomethyl-1,2,4-oxadiazol-5-yl)-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one of m.p. 237°-239°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-d985aac4815d4ad691e9b3f728e4b553 |
|---|
| Source note | uspto-grants-1997_09 |
|---|